As of 2025-07-04, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (1.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.85 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -275.3%.
The range of the Relative Valuation is (0.24) - (2.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.2x - 13.1x | 7.2x |
| Forward P/E multiples | 1.2x - 13.7x | 7.4x |
| Fair Price | (0.24) - (2.67) | (1.49) |
| Upside | -128.8% - -414.7% | -275.3% |
| Date | P/E |
| 2025-07-02 | -4.10 |
| 2025-07-01 | -4.04 |
| 2025-06-30 | -4.07 |
| 2025-06-27 | -4.31 |
| 2025-06-26 | -4.30 |
| 2025-06-25 | -4.23 |
| 2025-06-24 | -4.05 |
| 2025-06-23 | -3.92 |
| 2025-06-20 | -3.87 |
| 2025-06-18 | -3.94 |
| 2025-06-17 | -3.97 |
| 2025-06-16 | -4.17 |
| 2025-06-13 | -4.07 |
| 2025-06-12 | -4.23 |
| 2025-06-11 | -4.31 |
| 2025-06-10 | -4.34 |
| 2025-06-09 | -4.48 |
| 2025-06-06 | -4.41 |
| 2025-06-05 | -4.22 |
| 2025-06-04 | -4.20 |
| 2025-06-03 | -4.18 |
| 2025-06-02 | -4.25 |
| 2025-05-30 | -3.81 |
| 2025-05-29 | -3.73 |
| 2025-05-28 | -3.99 |
| 2025-05-27 | -4.12 |
| 2025-05-23 | -4.08 |
| 2025-05-22 | -4.27 |
| 2025-05-21 | -4.27 |
| 2025-05-20 | -4.62 |
| 2025-05-19 | -4.82 |
| 2025-05-16 | -4.76 |
| 2025-05-15 | -4.83 |
| 2025-05-14 | -5.05 |
| 2025-05-13 | -4.36 |
| 2025-05-12 | -4.10 |
| 2025-05-09 | -4.00 |
| 2025-05-08 | -3.97 |
| 2025-05-07 | -3.98 |
| 2025-05-06 | -4.08 |
| 2025-05-05 | -4.31 |
| 2025-05-02 | -4.19 |
| 2025-05-01 | -4.13 |
| 2025-04-30 | -4.40 |
| 2025-04-29 | -3.90 |
| 2025-04-28 | -3.64 |
| 2025-04-25 | -3.71 |
| 2025-04-24 | -3.59 |
| 2025-04-23 | -3.62 |
| 2025-04-22 | -3.25 |